Mitchell secures European cannabis license


Whilst some other ASX listed medical marijuana companies are still trying to fully understand the opportunities around medicinal cannabis, the Brett Mitchell chaired MGC Pharmaceuticals is about to start producing its first cannabis based medicinal products. Just 2.5 years after being back-door listed into Erin Resources by Mitchell, a well connected West Perth corporate finance virtuoso, MGC has already developed its first medicinal cannabis product and built a cutting edge manufacturing facility in Slovenia. This week the company announced it had received a manufacturing license for that facility and it is now putting plans in place to commence production of its heralded medicinal cannabis product known as CannEpil. MGC developed CannEpil to assist epilepsy sufferers to control their epilepsy, particularly in circumstances where traditional drugs are having no impact. The company will now begin full scale manufacturing of its orally-administered CannEpil for final, independent validation before exportation into Australasia and Europe. Mitchell secures European cannabis license

thumbnail courtesy of


Please enter your comment!
Please enter your name here